BIO-key International
BKYI
1 hedge funds and large institutions have $190K invested in BIO-key International in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
28% less capital invested
Capital invested by funds: $264K → $190K (-$74K)
80% less funds holding
Funds holding: 5 → 1 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$44K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$26K |
| 3 |
Renaissance Technologies
New York
|
-$22K |
| 4 |
Millennium Management
New York
|
-$19K |
BKYI Hedge Fund Activity: Q1 2018 in Review
1 of the 4,372 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q1 2018, worth a combined $190K — down 28% from $264K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BKYI and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Perkins Capital Management, exiting entirely with an estimated $44K sold.
- 1 institutional investor held BIO-key International (BKYI) as of Q1 2018, down from 5 in Q4 2017.
- Funds reported $190K of BIO-key International stock for Q1 2018, down 28% quarter-over-quarter.
- 0 funds opened new BIO-key International positions in Q1 2018 and 4 closed out, a net change of -4 holders.
- The largest BIO-key International seller in Q1 2018 was Perkins Capital Management, an estimated $44K sold.
Based on aggregated 13F filings for Q1 2018.